A differential expression pattern of spermidine/spermine N 1 -acetyltransferase (SSAT), the enzyme critical to proper homeostasis of cellular polyamines, is reported in mouse kidney undergoing hyperplasia and hypertrophy. We have shown that SSAT activity and SSAT mRNA are significantly induced by antifolate CB 3717 and folate that evoke a drug-injury-dependent hyperplasia. In contrast, SSAT activity is down-regulated in the testosterone-induced hypertrophic kidney, while SSAT mRNA is positively controlled by this androgen. Catecholamine depletion evoked by reserpine drastically decreases the folate-induced activity of S-adenosylmethionine decarboxylase (AdoMetDC), which limits polyamine biosynthesis, but has no effect on SSAT activity augmented by CB 3717. Our results document that the increased SSAT expression solely accompanies the proliferative response of mouse kidney, and suggest the importance of post-transcriptional regulation to the control of SSAT activity in both hyperplastic and hypertrophic experimental models.
death (Pegg, 1988; Igarashi & Kashiwagi, 2000; . Among the many functional roles of polyamines in the cell (such as protein synthesis, membrane stability, chromatin structure or modulation of ion channels), recent reports reveal their role in the transduction of death signals in apoptosis (Stefanelli et al., 2002) and in transcription, by regulation of the interactions of transcription factors with their response elements (Shah et al., 2001) . Furthermore, the recent discovery of a polyamine-responsive element in the SSAT gene and transacting proteins responding to polyamines, documents that polyamines can both directly and indirectly regulate gene expression (Wang et al., 1998; .
The intracellular polyamine pool appears to be precisely controlled by various homeostatic responses that typically include polyamine biosynthesis, catabolism, uptake, and excretion. The highly regulated polyamine metabolic pathway is finely controlled in both anabolic and catabolic directions. Three inducible enzymes, ODC, AdoMetDC (controlling polyamine biosynthesis), and SSAT are involved in this regulation. SSAT regulates the pathway governing the interconversion/degradation of cell polyamines (Seiler, 1987; Casero & Pegg, 1993; Xiao & Casero, 1995) . It acetylates higher polyamines that are either excreted from the cell or acted upon by polyamine oxidase, leading to a back-conversion of spermine to spermidine and spermidine to putrescine. This important enzyme prevents the overaccumulation of polyamines by facilitating their excretion and degradation, thereby playing a key role in the regulation of intracellular polyamines. SSAT activity is normally very low in the cell. However, this highly inducible enzyme responds to many physiological and non-physiological stimuli including natural polyamines and their analogues. Therefore, SSAT has been considered a homeostatic mechanism preventing the accumulation of polyamines to high cytotoxic levels. A report on the physiological polyamine level maintained in transgenic mouse overexpressing ODC and AdoMetDC due to a compensatory, increased activity of SSAT points to the crucial role of this enzyme in polyamine homeostasis (Heljasvaara et al., 1997) . We have previously shown that homeostasis of intracellular polyamine pools was profoundly disturbed in female mouse kidney that underwent either hyperplasia or hyperthrophy after mouse treatment with a quinazoline analogue of folic acid, CB 3717 or the steroid hormone, testosterone, respectively (Manteuffel-Cymborowska et al., 1993) . In mouse kidney CB 3717-induced injury of tubular epithelium was followed by regenerative hyperplasia. In contrast, an androgen-induced anabolic, non-proliferative response resulted in a hypertrophic kidney. However, in both cases, ODC activity and the ODC transcript level were greatly enhanced while modulation of AdoMetDC activity depended upon the kidney experimental model (Manteuffel-Cymborowska et al., 1992; .
In this paper we present the in vivo data on the differential modulation of SSAT expression in hyperplastic and hypertrophic mouse kidney. Moreover, we show that, in contrast to both polyamine biosynthetic enzymes, catecholamines are not prerequisite for induction of SSAT activity.
MATERIALS AND METHODS
Animal experimental model and drug administration. Swiss female mice (2.5-3 months old) were injected with testosterone (5 days, 125 mg/kg, s.c.) dissolved in soybean oil or for the period indicated with quinazoline antifolate CB 3717 or folate (300 mg/kg, i.p. or 250 mg/kg, i.p., respectively) dissolved in phosphate-buffered saline (PBS) adjusted with a few drops of 1 M NaOH to final pH 9-9.5. Control animals received either soybean oil or PBS, respectively. Anti-androgen casodex (40 mg/kg, s.c.) was injected 1 h be-fore testosterone and reserpine (10 mg/kg, i.p.) was given 1 h before CB 3717 or folate. The experimental details are given in the legends to the appropriate figures. The mice were killed by cervical dislocation, the kidneys were removed, weighed, cut into several pieces and used immediately for enzyme determinations, or were frozen at -70°C and processed later for Northern blot analysis. Experiments on the animals were carried out in accordance with the Polish regulations, which closely match the Convention No. 123 of the European Council. Enzyme activities and Northern blot analysis. The kidney pieces were immediately homogenized in appropriate buffers and processed for assays of SSAT (Stefanelli et al., 1987) and AdoMetDC (Pegg & Põsõ, 1983) . The mean specific activities of SSAT and AdoMetDC in kidneys of control female mice (12-14 animals) were 0.47 ± 0.13 and 0.24 ± 0.05 nmol/h per mg protein, respectively. For Northern blot analysis total RNA was isolated, subjected to gel electrophoresis, and blotted on nylon membranes; the levels of the selected mRNA species were then estimated as described (Manteuffel-Cymborowska et al., 1997) . The probe used was an insert coding a fragment of SSAT cDNA in the BamHI site of plasmid pETSSAT. The level of SSAT mRNA was quantified by densitometric scanning of the autoradiograms with a Molecular Dynamics Personal Laser Densitometer (Image Quant software) and corrected for total RNA loaded on the gels as determined by ethidium bromide staining of 28S RNA. Protein concentrations were estimated by the method of Lowry (Lowry et al., 1951) . Data were analysed statistically by the Mann-Whitney test.
Thymidine incorporation. To determine thymidine incorporation into acid-insoluble material, the mice were injected with [methyl-3 H]thymidine (i.p., 10 mg/kg; 0.67
MBq/25 g) 1 h prior to sacrifice. The kidneys were dissected and processed as described (Manteuffel-Cymborowska et al., 1993 
RESULTS AND DISCUSSION

CB 3717 and folate up-regulate SSAT expression
Antifolate CB 3717 and folate, when applied at high doses, induce renal damage owing to their precipitation in renal tubules at physiological pH (Newell et al., 1986; Mauer, 1986) . The consequence of this acute renal injury is regeneration of the tubule epithelium leading to kidney hyperplasia. As shown previously in the CB 3717-induced hyperplastic kidney a proliferative response was correlated with the induction of the activities of two decarboxylases, ODC and AdoMetDC, controling polyamine biosynthesis (Manteuffel-Cymborowska et al., 1993) .
The activity of SSAT, the enzyme limiting polyamine interconversion and degradation, is also significantly increased by CB 3717 (Figs. 1 and 2) and folate (not shown). This is consisted with a several-fold increase in SSAT product, N 1 -acetylspermidine and a significant decrease in its substrate, spermine, in Vol. 49 Proliferative vs anabolic SSAT response in kidney 971 kidneys undergoing regenerative hyperplasia, but not hypertrophy (Manteuffel-Cymborowska et al., 1993) , where SSAT induction does not occur (shown below). Moreover, our findings extend and confirm an earlier report on the effect of folate on SSAT activity (Matsui & Pegg, 1982) . The time course analysis reveals that the highest induction of SSAT activity occurs one day after antifolate treatment ( Fig. 2) , similarly to the induction of ODC and AdoMetDC (Manteuffel-Cymborowska et al., 1993) . However, the enhancement of SSAT activity is distinctly lower than that of ODC, being comparable with the induction of AdoMetDC by CB 3717 (Manteuffel-Cymborowska et al., 1993) or folate (shown below, Fig. 5 ).
Northern analysis shows that SSAT mRNA expression is also up-regulated both in the antifolate-and folate-induced hyperplastic kidneys (Figs. 2 and 3 ) with the folate induction of the SSAT mRNA equal to 3.93 ± 0.31, (n = 3). The pattern of increase in SSAT mRNA by CB 3717 strictly parallels that of SSAT activity, although it is higher at each examined time interval. This is in contrast with ODC expression increase in the CB 3717-induced hyperplastic kidney or testosterone-induced hypertrophic kidney where the enzyme activity is many fold higher than that of mRNA (Manteuffel-Cymborowska et al., 1997; Dudkowska et al., 1999; . A higher up-regulation of the SSAT mRNA than of SSAT activity, although rare, is not an exception. A similar observation was also found in proliferating rat thymocytes (Desiderio et al., 1995) , in the COS-7 cells (Parry et al., 1995) and in hepatocarcinoma cells (Desiderio et al., 1998) . These data indicate that, under the above experimental conditions, the increased transcription of the SSAT gene and/or mRNA stability are not sufficient for the up-regulation of SSAT expression and point to the critical role of post-transcriptional regulation for the control of SSAT activity.
Previously, we have documented that CB 3717 or folate induce the expression of the hepatocyte growth factor (HGF)/c-Met signalling pathway in the injured kidney (Dudkowska et al., 2001) . HGF induction of SSAT expression documented in vitro in hepatocarcinoma cells (Desiderio et al., 1998) CB 3717 was injected for one day, testosterone for five days, and casodex 1 h before testosterone administration. Relative values (means ± S.D.) of SSAT activity are given; each experimental group consisted of ten to twenty mice. ****P < 0.0001; ***P < 0.001; NS, non-significant as compared with control. The results are means ± S.D.; each experimental group consisted of three to twenty mice. ****P < 0.0001, **P < 0.01, *P < 0.05; NS, non-significant as compared with an appropriate control. seems to support the suggestion that up-regulated HGF/c-Met signalling can be involved in the induction of renal SSAT activity and SSAT mRNA in vivo.
Testosterone differentially modulates SSAT activity and SSAT mRNA
In mouse kidney, which is a testosterone responsive organ, androgens evoke a profound, nonproliferative response producing a marked hypertrophy of the proximal tubules and of the whole organ. In testosterone-evoked hypertrophic kidney, ODC and AdoMetDC show a different response -ODC expression is dramatically induced while that of AdoMetDC remains unaffected (Manteuffel-Cymborowska et al., 1992; . Thus, the lack of AdoMetDC induction differentiates the anabolic, testosterone-evoked response from the proliferative one, induced in kidney by antifolate or folate. The differences between the two murine kidney experimental models also apply to SSAT expression. Unlike CB 3717 or folate, testosterone does not induce, but significantly decreases, SSAT activity (Fig. 1 ). An over 40% reduction in SSAT activity evoked by testosterone is completely abolished by casodex, an anti-androgen (Fig. 1) , sugesting the involvement of the androgen receptor in SSAT regulation. In agreement with this finding is slightly lower SSAT activity in kidneys of male mice than in females correlated with the level of endogenous testosterone in both sexes (not shown).
The effect of testosterone on SSAT activity appeared to be tissue specific. In contrast to kidney, no statistically significant difference in SSAT activity was found in the liver of control and testosterone-treated mice, respec- Vol. 49 Proliferative vs anabolic SSAT response in kidney 973 tively (0.48 ± 0.11, n = 11 and 0.52 ± 0.12, n=17 nmol/h per mg protein). To our knowledge, there is no data on the direct relationship between SSAT activity and androgens. The only available report on the increase in SSAT activity after the administration of gossypol, an inhibitor of testosterone biosynthesis, and its decrease following testosterone application in canine prostate (Chang et al., 1997) are in line with our findings. The response of SSAT mRNA level to testosterone is different from that of SSAT activity. Thus, in contrast to the decreased SSAT activity observed in hypertrophic kidney, SSAT mRNA is induced by testosterone (Fig. 4) . This induction, although not very high, is statistically significant. It is decreased by casodex to a level significantly different from the level induced by testosterone, but indistinguishable (NS) from the control (Fig. 4) .
The results on the effect of testosterone on SSAT expression resemble the greater effect of antifolate CB 3717 on SSAT mRNA than on SSAT activity (Fig. 2) , and stress the importance of post-transcriptional regulation of SSAT expression.
Reserpine impairs folate-induced AdoMetDC activity but not CB 3717-induced SSAT activity
As shown previously, catecholamines are required both for androgen-and antifolate-induced renal ODC expression (Manteuffel-Cymborowska et al., 1997; Dudkowska et al., 1999) . The spectacular decrease in ODC activity and its transcript level in catecholamine-depleted kidneys points to cross talk between the examined signalling pathways.
The activity of AdoMetDC, which also limits polyamine biosynthesis, is 2.5-fold increased by folate (P < 0.0001, Fig. 5A ), in agreement with previously reported induction of this enzyme by antifolate (Manteuffel-Cymborowska et al., 1993) . To evaluate the role of catecholamines in AdoMetDC induction by folate we have applied in our experiments reserpine, a drug known to produce catecholamine depletion. Reserpine administered prior to folate not only prevents the increase in AdoMetDC activity, but also reduces this activity below the control level (Fig. 5A ). It appears, therefore, that AdoMetDC expression is catecholamine-dependent similarly to the ODC expression in mouse kidney (Manteuffel-Cymborowska et al., 1997; Dudkowska et al., 1999) or rat liver. In the latter, depletion of catecholamines or blocking of adrenoreceptors prevented stimulation of ODC activity by glucorticoid and laparatomy (Corti et al., 1985; Astancolle et al., 1991) . Moreover, agonists of catecholamine receptors induced ODC expression in mouse kidney (Dudkowska et al., 1999) and in cells cultured in vitro (Juráni et al., 1996) , and also increased SSAT activity in rat parotid glands (Nilsson & Rosengren, 1993) .
At variance with the catecholamine control of AdoMetDC activity, the SSAT activity, which increases several-fold in the antifolate-induced hyperplastic kidney, is not in- Folate and CB 3717 were injected for one day, reserpine 1 h before folate or CB 3717. Relative values (means ±S.D.) of AdoMetDC and SSAT activity are given; each experimental group consisted of four to fourteen mice. ****P < 0.0001; NS, non-significant as compared with folate (A) and CB 3717 (B).
fluenced by reserpine (Fig. 5B ). This result is rather unexpected. Reserpine-evoked catecholamine depletion attenuates the expression of both ODC and AdoMetDC and also decreases antifolate-induced kidney hyperplasia (Dudkowska et al., 1999) . Under these conditions, a decrease rather than an increase in the intracellular polyamine content could be expected since the induced SSAT activity would lead to further depletion of intracellular polyamines.
The findings presented here provide evidence that induction of SSAT expression is part of the proliferative response evoked in the CB 3717-or folate-injured hyperplastic kidney but not of the androgen-induced anabolic response in hypertrophic kidney. It is not clear why SSAT activity, known to respond to the polyamine pool, is not decreased under the conditions of catecholamine depletion. However, compensatory mechanisms such as increased polyamine uptake and/or decreased excretions of these polycations, preserving to some extent polyamine homeostasis, could provide an explanation. At present the question remains unanswered and deserves further studies.
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